Suppr超能文献

谁等待心肺移植的时间最长?

Who waits longest for heart and lung transplantation?

作者信息

Sharples L, Belcher C, Dennis C, Higenbottam T, Wallwork J

机构信息

Medical Research Council Biostatistics Unit, University Forvie Site, Cambridge, United Kingdom.

出版信息

J Heart Lung Transplant. 1994 Mar-Apr;13(2):282-91.

PMID:8031813
Abstract

Between August 1982 and December 1992, 260 patients were accepted for heart and lung transplantation, of whom 139 patients underwent transplant surgery. One hundred twenty-one patients have not received transplants, of whom 80 have died, four were transferred to other lists, and 37 were still waiting for suitable organs at the close of the study. Median waiting time for those patients who underwent heart and lung transplantation was 7 months, whereas patients who died waiting spent a median of 5 months on the list. Recipients are matched to donor organs according to blood type, size (total lung capacity), and cytomegalovirus antibody status. These factors, along with age, gender, underlying diagnosis, and Toxoplasma antibody status, were studied to assess their influence on survival after acceptance and time to transplantation. The only characteristic that significantly influenced survival after acceptance was the underlying disease, with patients with Eisenmenger's syndrome having significantly longer survival than the other groups (relative risk = 0.21; p < 0.001). Patients with Eisenmenger's syndrome underwent transplantation at a slower rate than did other patients (relative risk = 0.51; p = 0.012). Patients who had a total lung capacity of more than 6 L underwent transplantation significantly more quickly than did smaller patients (relative risk = 1.98; p = 0.005). Male patients underwent heart and lung transplantation at a quicker rate than did female patients (relative risk = 1.86; p < 0.001), although this was related to size. Patients who had cytomegalovirus-positive antibodies underwent transplantation at almost twice the rate of patients who had cytomegalovirus-negative antibodies (relative risk = 1.92; p < 0.001). Age at acceptance, blood type, and Toxoplasma status did not significantly influence time to heart and lung transplantation. In summary, cytomegalovirus antibody status, patient size, and gender significantly affect the waiting time to heart and lung transplantation. Patients with Eisenmenger's syndrome wait longer than other patients as a result of the natural history of their disease.

摘要

1982年8月至1992年12月期间,260例患者被纳入心肺移植项目,其中139例患者接受了移植手术。121例患者未接受移植,其中80例死亡,4例转至其他名单,37例在研究结束时仍在等待合适的器官。接受心肺移植的患者中位等待时间为7个月,而等待中死亡的患者在名单上的中位时间为5个月。接受者根据血型、体型(肺总量)和巨细胞病毒抗体状态与供体器官进行匹配。研究这些因素以及年龄、性别、基础诊断和弓形虫抗体状态,以评估它们对接受后生存及移植时间的影响。唯一显著影响接受后生存的特征是基础疾病,艾森曼格综合征患者的生存期明显长于其他组(相对风险=0.21;p<0.001)。艾森曼格综合征患者接受移植的速度比其他患者慢(相对风险=0.51;p=0.012)。肺总量超过6L的患者接受移植的速度明显快于体型较小的患者(相对风险=1.98;p=0.005)。男性患者接受心肺移植的速度比女性患者快(相对风险=1.86;p<0.001),尽管这与体型有关。巨细胞病毒抗体阳性的患者接受移植的速度几乎是抗体阴性患者的两倍(相对风险=1.92;p<0.001)。接受时的年龄、血型和弓形虫状态对心肺移植时间没有显著影响。总之,巨细胞病毒抗体状态、患者体型和性别显著影响心肺移植的等待时间。由于疾病的自然病程,艾森曼格综合征患者等待时间比其他患者更长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验